Total Revenue
Markel Total Revenue decreased by 11.4% to $3.55B in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 0.1%, from $3.55B to $3.55B. Over 4 years (FY 2021 to FY 2025), Total Revenue shows an upward trend with a 5.8% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.
Analysis
How to read this metric
An increase indicates market expansion or higher demand, while a decrease may signal market saturation or competitive pressure.
Detailed definition
Total revenue represents the gross inflow of economic benefits arising from the ordinary operating activities of the com...
Peer comparison
Standard across all public companies; peers in the medical device and diagnostics sector typically show steady growth correlated with product adoption.
total_revenueHistorical Data
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $3.50B | $2.69B | $3.76B | $2.61B | $1.79B | $3.07B | $4.21B | $3.64B | $4.14B | $3.38B | $3.12B | $4.47B | $3.70B | $3.69B | $3.72B | $3.55B | $4.60B | $3.93B | $4.01B | $3.55B |
| QoQ Change | — | -23.2% | +39.8% | -30.7% | -31.2% | +71.1% | +37.3% | -13.5% | +13.7% | -18.5% | -7.6% | +43.2% | -17.1% | -0.2% | +0.8% | -4.7% | +29.7% | -14.5% | +1.9% | -11.4% |
| YoY Change | — | — | — | — | -48.8% | +14.1% | +12.0% | +39.8% | +131.1% | +10.1% | -25.9% | +22.6% | -10.6% | +9.4% | +19.4% | -20.6% | +24.3% | +6.5% | +7.6% | +0.1% |
Product Breakdown
| Segment | Q1 '23 | Q2 '23 | Q3 '23 | Q1 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q1 '26 |
|---|---|---|---|---|---|---|---|---|
| Services | $489.34M | $571.18M | $598.36M | $500.42M | $510.75M | $650.64M | $681.39M | $546.43M |
| Management Fees | — | — | — | — | $25.87M | $29.58M | $30.34M | $41.55M |
| Disposition gain | $0.00 | $16.92M | — | — | — | — | — | — |
| Other Revenues | $51.55M | $47.42M | $53.08M | — | — | — | — | — |
| Total | $3.64B | $4.14B | $3.38B | $4.47B | $3.55B | $4.60B | $3.93B | $3.55B |
Disposition gain, Other Revenues were previously reported and have since been discontinued or reclassified. Only currently active segments are shown in the chart.
Business Segments
| Segment | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 |
|---|---|---|---|---|---|---|---|---|
| Industrial | — | — | — | — | — | $1.01B | $986.91M | $846.75M |
| Consumer and Other | — | — | — | — | — | $273.23M | $256.94M | $261.91M |
| Financial | — | — | — | — | — | $30.78M | $76.22M | $41.81M |
| Markel Insurance | — | — | — | — | — | $1.20M | $5.77M | $1.54M |
| Corporate Expense | $0.00 | $0.00 | $0.00 | — | — | — | — | — |
| Corporate Operations | — | — | — | — | — | $0.00 | $0.00 | $0.00 |
| Insurance | $1.85B | $1.85B | $1.85B | — | — | — | — | — |
| Investing | $693.24M | $693.24M | $693.24M | — | — | — | — | — |
| Markel Ventures | $1.41B | $1.22B | $1.40B | $1.06B | $1.49B | — | — | — |
| Reinsurance | $257.05M | $257.05M | $257.05M | — | — | — | — | — |
| Total | $3.70B | $3.69B | $3.72B | $3.55B | $4.60B | $3.93B | $4.01B | $3.55B |
Corporate Expense, Insurance, Investing, Reinsurance are derived from annual filings.
Corporate Expense, Insurance, Investing, Markel Ventures, Reinsurance were previously reported and have since been discontinued or reclassified. Only currently active segments are shown in the chart.
Total Revenue at Other Companies
Frequently Asked Questions
- What is Markel's total revenue?
- Markel (MKL) reported total revenue of $3.55B in Q1 2026.
- How has Markel's total revenue changed year-over-year?
- Markel's total revenue increased by 0.1% year-over-year, from $3.55B to $3.55B.
- What is the long-term trend for Markel's total revenue?
- Over 4 years (2021 to 2025), Markel's total revenue has grown at a 5.8% compound annual growth rate (CAGR), from $12.85B to $16.09B.
- What does total revenue mean?
- The total amount of money a company brings in from its primary business activities before any expenses.